A case of restless legs syndrome after BNT162b2 mRNA COVID-19 vaccination.

Hisashi ItoTakahiro KurokiShigeto HoriuchiYuichi Shinya

Published in: Neurology and clinical neuroscience (2022)

Restless legs syndrome (RLS) can be secondary to several disorders. We present an 87-year-old woman who developed RLS 2 days after the first injection of BNT162b2 mRNA coronavirus disease 2019 vaccine. The symptoms of RLS tended to improve and eventually resolved with the administration of gabapentin.

Keyphrases

coronavirus disease
case report
sars cov
respiratory syndrome coronavirus
binding protein
neuropathic pain
physical activity
depressive symptoms
sleep quality